Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesalazine (PENTASA®) in Ulcerative Colitis: Correlation of the Information Level With Patient's Compliance in Everyday Practice

NCT01517607 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT01517607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01517607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesalazine (PENTASA®) in Ulcerative Colitis: Correlation of the Information Level With Patient's Compliance in Everyday Practice
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2013
Enrollment
506 (actual)
Sites
149

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis